Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07394036 · ClinicalTrials.gov registry record · Phase 2
Effect of Ipratropium Bromide on EILO
A Phase 2 study, sponsored by Cook Children's Health Care System.
- Not yet
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT07394036 is a Phase 2 study that has not yet begun recruiting, run by Cook Children's Health Care System. The registered enrollment target is 50 participants.
The verdict
NCT07394036, a Phase 2 study, has not yet begun recruiting, sponsored by Cook Children's Health Care System.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators propose a study that compares breathlessness and airway obstruction during intense exercise in 34 children and adolescents with Exercise-Induced Laryngeal Obstruction after breathing in ipratropium bromide or placebo. It is hypothesized that breathlessness and airway obstruction will be lower following breathing in ipratropium bromide compared with placebo.
Interventions
- DRUG Normal Saline (Placebo)
- DRUG Ipratropium Bromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07394036
The ClinicalTrials.gov registry entry for NCT07394036 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Children's Health Care System, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline (Placebo) is the first listed.
NCT07394036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07394036 about?
NCT07394036 is a clinical study titled "Effect of Ipratropium Bromide on EILO". The investigators propose a study that compares breathlessness and airway obstruction during intense exercise in 34 children and adolescents with Exercise-Induced Laryngeal Obstruction after breathing in ipratropium bromide or placebo. It is hypothesized that breathlessness and airway obstruction wi...
What is the current status of trial NCT07394036?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2026-06-01. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07394036?
The interventions under investigation include: Normal Saline (Placebo) (DRUG), Ipratropium Bromide (DRUG).
Who is sponsoring clinical trial NCT07394036?
This trial is sponsored by Cook Children's Health Care System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.